BRIEF-Merck KGAA and Pfizer receive FDA breakthrough status for Avelumab By: Reuters: Company News November 18, 2015 at 07:08 AM EST * Merck KGAA and Pfizer receive FDA breakthrough therapy designation for Avelumab in metastatic merkel cell carcinoma Read More >> Related Stocks: Merck & Co Pfizer